ROZACEE

DOI: 10.7241/ourd.2022book.2_2

First Page (Prima pagina)

Rozaceea este o dermatoză inflamatorie cronică a fe?ei, diagnosticată rar la copii, uneori cu antecedente familiale. Inciden?a ?i prevalen?a rozaceei la copii sunt necunoscute, de?i cele mai multe cazuri au fost raportate la copii cu vârsta 4-5 ani, fără preferin?ă pe gen.
Rozaceea la copii are aspecte clinice ?i terapeutice particulare [1-3].
Cel mai frecvent este descrisă forma papulo-pustuloasă, cu leziuni localizate pe păr?ile convexe ale fe?ei (în special obraji, rar menton); leziunile papulo-pustuloase au un fond eritematos?i se pot asocia cu telangiectazii fine. Flush-ul apare mult mai rar la copii, în special în caz de varia?ii bru?te de temperatură. Rozaceea granulomatoasă este frecvent iatrogenă, după aplicarea de steroizi poten?i timp îndelungat; este foarte rară la copii ?i, uneori greu de diferen?iat de dermita granulomatoasă periorală. Rozaceea fimatoasă nu apare la copii [3-6].
Demodecidoza la copilul imunocompetent este foarte rară; diagnosticul clinic trebuie confirmat prin eviden?ierea parazitului, în cantitate mare, la biopsie sau proba de grataj. Leziunile în demodecidoză sunt pruriginoase, numeroase ?i cu aspect inflamator; debutul leziunilor cutanate este brusc, evolu?ia nu este lent-progresivă ca în rozacee ?i nu există afectare oftalmologică [7-9].
Nu există consens privind clasificarea clinică a rozaceei la copii, dar se admite prezen?a următoarelor forme clinice [10]:
1. Forma telangiectazică caracterizată prin eritem persistent (cronic) sau flush indus de expunerea la căldură sau ultraviolete ?i cu o durată de câteva minute (Fig. 1a ?i 1b). Eritemul poate fi asociat leziunilor papulo-pustuloase.

Keywords

  • Rozaceea; Acid azelaic; Permetrină; Ivermectină; Tacrolimus; Benzoil peroxid; Doxiciclină; Eritromicină; Ivermectină; Metronidazol; Isotretinoin; Dermita periorală este; 

References

1. Goel NS, Burkhart CN, Morrell DS. Pediatric periorificial dermatitis: clinical course and treatment outcomes in 222 patients. Pediatr Dermatol. 2015;32:333-6.
2. Nguyen V, Eichenfield LF. Periorificial dermatitis in children and adolescents. J Am Acad Dermatol. 2006;55:781-5.
3. Boralevi F, Le?aute?-Labreze C, Lepreux S, et al. Idiopathic facial aseptic granuloma : a multicentre prospective study of 30 cases. Br J Dermatol. 2007;156:705-8.
4. Chamaillard M, Mortemousque B, Boralevi F, et al. Cutaneous and ocular signs of childhood rosacea. Arch Dermatol. 2008;144:167-71.
5. Zitelli KB, Sheil AT, Fleck R, et al. Idiopathic Facial Aseptic Granuloma: Review of an Evolving Clinical Entity. Pediatr Dermatol. 2015;32:e136-9.
6. Le?aute?-Labre?ze C, Chamaillard M. Paediatric rosacea. Ann Dermatol Venereol. 2007;134:788-92.
7. Noguera-Morel L, Gerlero P, Torrelo A, et al. Ivermectin therapy for papulopustular rosacea and periorificial dermatitis in children: A series of 15 cases. J Am Acad Dermatol. 2017;76:567-70.
8. Patrizi A, Neri I, Chieregato C, et al. Demodecidiosis in immunocompetent young children: report of eight cases. Dermatology. 1997;195:239-42.
9. Douglas A, Zaenglein AL. A case series of demodicosis in children. Pediatr Dermatol. 2019;36:651-4.
10. Noguera-Morel L, Hernández-Martín A, Torrelo A. Childhood rosacea and related disorders. Clin Exp Dermatol. 2021;46:430-43.
11. Sayhi S, Mezri S, Ben Abdelhafi dh N. Ophthalmic rosacea in a patient with Takayasu disease. Our Dermatol Online. 2020;11:83.
12. Knopfel N, G omez-Zubiaur A, Noguera-Morel L, et al. Ultrasound findings in idiopathic facial aseptic granuloma: case series and literature review. Pediatr Dermatol. 2018;35:397?400.
13. Chamaillard M, Mortemousque B, Boralevi F, et al. Cutaneous and ocular signs of childhood rosacea. Arch Dermatol. 2008;144:167?71.
14. Neri I, Raone B, Dondi A, et al. Should idiopathic facial aseptic granuloma be considered granulomatous rosacea? Report of three pediatric cases. Pediatr Dermatol. 2013;30:109?11.
15. Crawford GH, Pelle M, James WD. Rosacea: etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51:327-41.

16. Aldrich N, Gerstenblith M, Fu P, et al. Genetic vs environmental factors that correlate with rosacea: a cohort-based survey of twins. JAMA Dermatol. 2015;151: 1213?19.
17. Suarez-de-Ocariz M, Suarez-Gutierrez M, Migaud M, et al. Rosacea as a striking feature in family members with a STAT1 gain-of-function mutation. J Eur Acad Dermatology Venereol. 2020;34:e265?7.
18. Ahn CS, Huang WW. Rosacea pathogenesis. Dermatol Clin. 2018;36:81?6.
19. Amir Ali A, Vender R, Vender R. The role of IL-17 in papulopustular rosacea and future directions. J Cutan Med Surg. 2019;23:635?41.
20. Vanhooteghem O, Theate I, Algoet C. Unexpected discovery of asymptomatic polycythemia vera in a patient with papulopustular rosacea caused by Demodex: A fortuitous association? Our Dermatol Online. 2021;12:291-3.
21. Sener S, Kilinc F, Akbas A, et al. Decreased arylesterase activity and increased total oxidative status in rosacea. Our Dermatol Online. 2017;8:385-8.
22. Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci. 2009;55:77?81.
23. van Zuuren EJ, Fedorowicz Z. Interventions for rosacea. JAMA. 2015;314:2403.
24. Thiboutot DM, Fleischer AB, Del Rosso JQ, et al. Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. J Drugs Dermatol. 2008;7:541?6.
25. Koçak M, Ya?li S, Vahapo?lu G, et al. Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study. Dermatology. 2002;205:265-70.
26. Schaller M, Gonser L, Belge K, et al. Dual antiinflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea. J Eur Acad Dermatol Venereol. 2017;31:1907?11.
27. Ollech A, Yousif R, Kruse L, et al. Topical calcineurin inhibitors for pediatric periorificial dermatitis. J Am Acad Dermatol. 2020;82:1409?14.
28. Gonser LI, Gonser CE, Deuter C, et al. Systemic therapy of ocular and cutaneous rosacea in children. J Eur Acad Dermatol Venereol. 2017;31:1732?8.
29. Schaller M, Kemény L, Havlickova B, et al. A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea. J Am Acad Dermatol. 2020;82:336?43.
30. Levy M, Martin L, Bursztejn AC, et al. Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study. Br J Dermatol. 2020;182:1003?6.
31. Cantarutti N, Claps A, Angelino G, et al. Multi-drugs resistant acne rosacea in a child affected by ataxiatelangiectasia: successful treatment with isotretinoin. Ital J Pediatr. 2015;41:23.
32. Zaouak A, Bouhajja L, Jannet SB, et al. Facial granulomatous periorificial dermatitis in a Tunisian child. Our Dermatol Online. 2018;10:181-3.
33. Bimbi C, Brzezinski P. Rosacea-like Tinea Faciei. Our Dermatol Online. 2016;7:78-80.

Comments are closed.